The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting

Yong Il Chung, Jong Chul Kim, Young Ha Kim, Giyoong Tae, Seung Young Lee, Kwang Meyung Kim, Ick Chan Kwon

Research output: Contribution to journalArticle

114 Citations (Scopus)

Abstract

The poly (lactide-co-glycolide) (PLGA)-based nanoparticles, coated by the heparin- or chitosan-Pluronic conjugate, were used to improve a relatively low tumor-targeting efficiency of the bare PLGA nanoparticles. The prepared nanoparticles were in the size range of 100-150. nm, and the surface exposure of the functional moiety (heparin or chitosan) was confirmed by negatively or positively increased zeta potential values, respectively. The viability tests for both normal and tumor cells displayed minimal cytotoxicity of the nanoparticles. The stable surface coating, which was evident from no change in the size distribution profiles in spite of the surface charge changes in serum environment, effectively provided the desired functionalized surface that clearly enhanced the in vitro cellular uptake of the nanoparticles for both heparin and chitosan functionalization. The in vivo tumor model study, which was carried out in SCC7 tumor-bearing athymic mice, demonstrated that there was a limited, but positive effect of surface functionalization, more effective for chitosan functionalization. The accumulation of chitosan-functionalized PLGA nanoparticles in tumor was 2.4 folds higher than that of the control, PLGA nanoparticles coated with bare Pluronic, and the accumulation in liver was lower than the control. In the case of heparin functionalization, the mean value was 2.2 folds higher than that of the control, but the accumulation in liver was similar to that of the control. Therefore, the surface-functionalization by the chitosan- or heparin-conjugated Pluronic may be an effective approach for the hydrophobic nanoparticle systems aiming for the enhanced tumor imaging and therapy.

Original languageEnglish
Pages (from-to)374-382
Number of pages9
JournalJournal of Controlled Release
Volume143
Issue number3
DOIs
Publication statusPublished - 2010 May 1
Externally publishedYes

Fingerprint

Poloxamer
Chitosan
Nanoparticles
Heparin
Neoplasms
Polyglactin 910
polylactic acid-polyglycolic acid copolymer
Liver
Nude Mice

Keywords

  • Cellular uptake
  • Chitosan
  • Heparin
  • PLGA nanoparticle
  • Surface functionalization
  • Tumor targeting

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting. / Chung, Yong Il; Kim, Jong Chul; Kim, Young Ha; Tae, Giyoong; Lee, Seung Young; Kim, Kwang Meyung; Kwon, Ick Chan.

In: Journal of Controlled Release, Vol. 143, No. 3, 01.05.2010, p. 374-382.

Research output: Contribution to journalArticle

Chung, Yong Il ; Kim, Jong Chul ; Kim, Young Ha ; Tae, Giyoong ; Lee, Seung Young ; Kim, Kwang Meyung ; Kwon, Ick Chan. / The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting. In: Journal of Controlled Release. 2010 ; Vol. 143, No. 3. pp. 374-382.
@article{81bdc959326f4934a58ea8ec1af96322,
title = "The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting",
abstract = "The poly (lactide-co-glycolide) (PLGA)-based nanoparticles, coated by the heparin- or chitosan-Pluronic conjugate, were used to improve a relatively low tumor-targeting efficiency of the bare PLGA nanoparticles. The prepared nanoparticles were in the size range of 100-150. nm, and the surface exposure of the functional moiety (heparin or chitosan) was confirmed by negatively or positively increased zeta potential values, respectively. The viability tests for both normal and tumor cells displayed minimal cytotoxicity of the nanoparticles. The stable surface coating, which was evident from no change in the size distribution profiles in spite of the surface charge changes in serum environment, effectively provided the desired functionalized surface that clearly enhanced the in vitro cellular uptake of the nanoparticles for both heparin and chitosan functionalization. The in vivo tumor model study, which was carried out in SCC7 tumor-bearing athymic mice, demonstrated that there was a limited, but positive effect of surface functionalization, more effective for chitosan functionalization. The accumulation of chitosan-functionalized PLGA nanoparticles in tumor was 2.4 folds higher than that of the control, PLGA nanoparticles coated with bare Pluronic, and the accumulation in liver was lower than the control. In the case of heparin functionalization, the mean value was 2.2 folds higher than that of the control, but the accumulation in liver was similar to that of the control. Therefore, the surface-functionalization by the chitosan- or heparin-conjugated Pluronic may be an effective approach for the hydrophobic nanoparticle systems aiming for the enhanced tumor imaging and therapy.",
keywords = "Cellular uptake, Chitosan, Heparin, PLGA nanoparticle, Surface functionalization, Tumor targeting",
author = "Chung, {Yong Il} and Kim, {Jong Chul} and Kim, {Young Ha} and Giyoong Tae and Lee, {Seung Young} and Kim, {Kwang Meyung} and Kwon, {Ick Chan}",
year = "2010",
month = "5",
day = "1",
doi = "10.1016/j.jconrel.2010.01.017",
language = "English",
volume = "143",
pages = "374--382",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting

AU - Chung, Yong Il

AU - Kim, Jong Chul

AU - Kim, Young Ha

AU - Tae, Giyoong

AU - Lee, Seung Young

AU - Kim, Kwang Meyung

AU - Kwon, Ick Chan

PY - 2010/5/1

Y1 - 2010/5/1

N2 - The poly (lactide-co-glycolide) (PLGA)-based nanoparticles, coated by the heparin- or chitosan-Pluronic conjugate, were used to improve a relatively low tumor-targeting efficiency of the bare PLGA nanoparticles. The prepared nanoparticles were in the size range of 100-150. nm, and the surface exposure of the functional moiety (heparin or chitosan) was confirmed by negatively or positively increased zeta potential values, respectively. The viability tests for both normal and tumor cells displayed minimal cytotoxicity of the nanoparticles. The stable surface coating, which was evident from no change in the size distribution profiles in spite of the surface charge changes in serum environment, effectively provided the desired functionalized surface that clearly enhanced the in vitro cellular uptake of the nanoparticles for both heparin and chitosan functionalization. The in vivo tumor model study, which was carried out in SCC7 tumor-bearing athymic mice, demonstrated that there was a limited, but positive effect of surface functionalization, more effective for chitosan functionalization. The accumulation of chitosan-functionalized PLGA nanoparticles in tumor was 2.4 folds higher than that of the control, PLGA nanoparticles coated with bare Pluronic, and the accumulation in liver was lower than the control. In the case of heparin functionalization, the mean value was 2.2 folds higher than that of the control, but the accumulation in liver was similar to that of the control. Therefore, the surface-functionalization by the chitosan- or heparin-conjugated Pluronic may be an effective approach for the hydrophobic nanoparticle systems aiming for the enhanced tumor imaging and therapy.

AB - The poly (lactide-co-glycolide) (PLGA)-based nanoparticles, coated by the heparin- or chitosan-Pluronic conjugate, were used to improve a relatively low tumor-targeting efficiency of the bare PLGA nanoparticles. The prepared nanoparticles were in the size range of 100-150. nm, and the surface exposure of the functional moiety (heparin or chitosan) was confirmed by negatively or positively increased zeta potential values, respectively. The viability tests for both normal and tumor cells displayed minimal cytotoxicity of the nanoparticles. The stable surface coating, which was evident from no change in the size distribution profiles in spite of the surface charge changes in serum environment, effectively provided the desired functionalized surface that clearly enhanced the in vitro cellular uptake of the nanoparticles for both heparin and chitosan functionalization. The in vivo tumor model study, which was carried out in SCC7 tumor-bearing athymic mice, demonstrated that there was a limited, but positive effect of surface functionalization, more effective for chitosan functionalization. The accumulation of chitosan-functionalized PLGA nanoparticles in tumor was 2.4 folds higher than that of the control, PLGA nanoparticles coated with bare Pluronic, and the accumulation in liver was lower than the control. In the case of heparin functionalization, the mean value was 2.2 folds higher than that of the control, but the accumulation in liver was similar to that of the control. Therefore, the surface-functionalization by the chitosan- or heparin-conjugated Pluronic may be an effective approach for the hydrophobic nanoparticle systems aiming for the enhanced tumor imaging and therapy.

KW - Cellular uptake

KW - Chitosan

KW - Heparin

KW - PLGA nanoparticle

KW - Surface functionalization

KW - Tumor targeting

UR - http://www.scopus.com/inward/record.url?scp=77952187189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952187189&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2010.01.017

DO - 10.1016/j.jconrel.2010.01.017

M3 - Article

VL - 143

SP - 374

EP - 382

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

IS - 3

ER -